Volume | 38 593 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 1,93 | Bas Haut |
|||||
Minimum Bas | 1,87 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Cognition Therapeutics Inc | CGTX | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
1,90 | 1,87 | 1,93 | 1,91 | 1,93 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
261 | 38 593 | US$ 1,89 | US$ 73 013 | - | 0,9001 - 3,49 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
22:23:53 | formt | 275 | US$ 1,86 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
58,1M | 30,42M | - | 0 | -25,79M | -0,85 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Cognition Therapeutics
Date | Heure | Source | Titre |
---|---|---|---|
11/3/2024 | 21:11 | Edgar (US Regulatory) | Form 8-K - Current report |
11/3/2024 | 21:06 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
20/2/2024 | 22:44 | Edgar (US Regulatory) | Form 8-K - Current report |
20/2/2024 | 22:13 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
20/2/2024 | 22:13 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
10/2/2024 | 01:12 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
19/1/2024 | 21:07 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
09/1/2024 | 06:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
08/1/2024 | 22:11 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] |
04/1/2024 | 22:21 | Edgar (US Regulatory) | Form 8-K - Current report |
04/1/2024 | 13:30 | GlobeNewswire Inc. | Cognition Therapeutics CEO Issues Letter to Shareholders |
29/12/2023 | 22:02 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
Forum Action Cognition Therapeutics
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Cognition Therapeutics Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 1,86 | 2,10 | 1,84 | 1,96 | 107 335 | 0,05 | 2,69% |
1 mois | 1,91 | 2,1599 | 1,79 | 1,97 | 128 406 | 0,00 | 0,00% |
3 mois | 2,30 | 2,4603 | 1,75 | 1,96 | 209 796 | -0,39 | -16,96% |
6 mois | 1,17 | 2,79 | 0,9001 | 1,89 | 191 339 | 0,74 | 63,25% |
1 an | 1,73 | 3,49 | 0,9001 | 1,91 | 157 103 | 0,18 | 10,40% |
3 ans | 12,15 | 13,80 | 0,9001 | 3,09 | 164 530 | -10,24 | -84,28% |
5 ans | 12,15 | 13,80 | 0,9001 | 3,09 | 164 530 | -10,24 | -84,28% |